Rankings / Metabolic Health

Pramlintide

Metabolic Health · Amylin analog (short-acting)

Tier B-

amylinprescription
6.1 / 10
Tier B-
Ev 8 Bn 3.5 Sf 5

Bottom line

Read Off Label grades Pramlintide as B- (6.1/10) based on strong evidence, low-med benefit magnitude, and a med-risk safety profile.

FDA-approved for T1D and T2D as insulin adjunct.

Studied, labeled, or reported-use context: Symlin: 60-120 mcg SC before meals — Rx; not individualized guidance.

Citation correction in progress

1 PubMed link was found to be unrelated to this entry and removed from public output. The remaining sources are shown below, but this row's claims and score still need a full source-by-source revalidation.

What the evidence says

FDA-approved for T1D and T2D as insulin adjunct. Modest weight loss (~1-2 kg) as pure weight-loss agent. Now largely superseded by long-acting cagrilintide and GLP-1s. Requires pre-meal injections.

Mechanism

Synthetic amylin analog; delays gastric emptying; suppresses glucagon and increases satiety; amylin co-secreted with insulin normally

Studied, labeled, or reported dose & route

Symlin: 60-120 mcg SC before meals

This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.

Citations

A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.

Common questions

What does the evidence show about Pramlintide's effects?
Read Off Label rates the evidence for Pramlintide as Strong and the benefit magnitude as low-med, producing an overall grade of B- (6.1/10). FDA-approved for T1D and T2D as insulin adjunct.
What safety findings are reported for Pramlintide?
Pramlintide has a med risk profile in the database. Med (nausea very common; severe hypoglycemia if used with insulin) Legal status: Rx.
What doses or routes are reported for Pramlintide?
Symlin: 60-120 mcg SC before meals This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
How does Pramlintide work?
Synthetic amylin analog; delays gastric emptying; suppresses glucagon and increases satiety; amylin co-secreted with insulin normally

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.